Inotrope and Vasopressor Therapy of Septic Shock

Critical Care Clinics

Volumn 25, Issue 4, 2009, Pages 781-802

  Hollenberg, Steven M ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Dopamine; Epinephrine; Inotrope; Norepinephrine; Sepsis; Septic shock; Vasopressin; Vasopressor

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT; LEVOSIMENDAN; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; VASOACTIVE AGENT; VASOPRESSIN;

CLINICAL TRIAL; CRITICAL ILLNESS; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FLUID RESUSCITATION; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOVOLEMIA; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; MONITORING; MYOCARDIAL DISEASE; NONHUMAN; PATHOGENESIS; PERFUSION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC AGENTS; ADRENERGIC ALPHA-AGONISTS; ANIMALS; CARDIAC OUTPUT; CARDIOTONIC AGENTS; DOPAMINE; EPINEPHRINE; HEMODYNAMICS; HUMANS; PHENYLEPHRINE; REGIONAL BLOOD FLOW; RESUSCITATION; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 70350608726     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.07.003     Document Type: Review

References (126)

1. Hollenberg S.M., and Parrillo J.E. Shock. In: Fauci A.S., Braunwald E., Isselbacher K.J., et al. (Eds). Harrison's principles of internal medicine. 14th edition (1997), McGraw-Hill, New York 214-222
2. Ince C., and Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 27 (1999) 1369-1377
3. Parrillo J.E., Parker M.M., Natanson C., et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113 (1990) 227-242
4. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
5. Cohn J.N. Blood pressure measurement in shock: mechanism of inaccuracy in ausculatory and palpatory methods. JAMA 199 (1967) 118-122
6. Hollenberg S.M., Ahrens T.S., Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32 (2004) 1928-1948
7. Task Force of the American College of Critical Care Medicine, Hollenberg S.M., Ahrens T.S., et al. Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 27 (1999) 639-660
8. Michard F., and Teboul J.L. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 121 (2002) 2000-2008
9. Bersten A.D., and Holt A.W. Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 3 (1995) 650-661
10. Kirchheim H.R., Ehmke H., Hackenthal E., et al. Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 410 (1987) 441-449
11. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
12. Desjars P., Pinaud M., Bugnon D., et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17 (1989) 426-429
13. Desjars P., Pinaud M., Tasseau F., et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 15 (1987) 134-137
14. Hesselvik J.F., and Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 17 (1989) 179-180
15. Fukuoka T., Nishimura M., Imanaka H., et al. Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 17 (1989) 1104-1107
16. Lipman J., Roux A., and Kraus P. Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 19 (1991) 61-65
17. Martin C., Eon B., Saux P., et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18 (1990) 282-285
18. Meadows D., Edwards J.D., Wilkins R.G., et al. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 16 (1988) 663-667
19. Redl-Wenzl E.M., Armbruster C., Edelmann G., et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19 (1993) 151-154
20. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28 (2000) 2729-2732
21. Bourgoin A., Leone M., Delmas A., et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33 (2005) 780-786
22. Levy B., Gibot S., Franck P., et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 365 (2005) 871-875
23. Friedman G., Berlot G., and Kahn R.J. Combined measurements of blood lactate levels and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 23 (1995) 1184-1193
24. Vincent J.L., Dufaye P., and Berre J. Serial lactate determinations during circulatory shock. Crit Care Med 11 (1983) 449-451
25. Weil M.H., and Afifi A.A. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure. Circulation 41 (1970) 989-1001
26. Reinhart K., Kuhn H.J., Hartog C., et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 30 (2004) 1572-1578
27. Varpula M., Karlsson S., Ruokonen E., et al. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med 32 (2006) 1336-1343
28. 2 uptake during bacteremia in the dog. J Appl Physiol 63 (1987) 1487-1489
29. De Backer D., Creteur J., Noordally O., et al. Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients?. Am J Respir Crit Care Med 157 (1998) 1219-1225
30. Sakr Y., Dubois M.J., De Backer D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32 (2004) 1825-1831
31. Creteur J., De Backer D., Sakr Y., et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 32 (2006) 516-523
32. Hoogenberg K., Smit A.J., and Girbes A.R.J. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 26 (1998) 260-265
33. Meier-Hellmann A., Bredle D.L., Specht M., et al. The effects of low-dose dopamine on splanchnic blood flow and oxygen utilization in patients with septic shock. Intensive Care Med 23 (1997) 31-37
34. Marik P.E., and Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272 (1994) 1354-1357
35. Hannemann L., Reinhart K., Grenzer O., et al. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 23 (1995) 1962-1970
36. Ruokonen E., Takala J., Kari A., et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 21 (1993) 1296-1303
37. Jardin F., Gurdjian F., Desfonds P., et al. Effect of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure. Crit Care Med 7 (1979) 273-277
38. Martin C., Papazian L., Perrin G., et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 103 (1993) 1826-1831
39. Winslow E.J., Loeb H.S., Rahimtoola S.H., et al. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54 (1973) 421-432
40. Regnier B., Safran D., Carlet J., et al. Comparative haemodynamic effects of dopamine and dobutamine in septic shock. Intensive Care Med 5 (1979) 115-120
41. Samii K., Le Gall J.R., Regnier B., et al. Hemodynamic effects of dopamine in septic shock with and without acute renal failure. Arch Surg 113 (1978) 1414-1416
42. Regnier B., Rapin M., Gory G., et al. Haemodynamic effects of dopamine in septic shock. Intensive Care Med 3 (1977) 47-53
43. Wilson R.F., Sibbald W.J., and Jaanimagi J.L. Hemodynamic effects of dopamine in critically ill septic patients. J Surg Res 20 (1976) 163-172
44. Meier-Hellmann A., and Reinhart K. Effects of catecholamines on regional perfusion and oxygenation in critically ill patients. Acta Anaesthesiol Scand Suppl 107 (1995) 239-248
45. Hiltebrand L.B., Krejci V., and Sigurdsson G.H. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 100 (2004) 1188-1197
46. Maynard N.D., Bihari D.J., Dalton R.N., et al. Increasing splanchnic blood flow in the critically ill. Chest 108 (1995) 1648-1654
47. Neviere R., Chagnon J.L., Vallet B., et al. Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med 25 (1997) 1371-1377
48. Guerin J.P., Levraut J., Samat-Long C., et al. Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. Shock 23 (2005) 18-24
49. Bellomo R., Chapman M., Finfer S., et al. Care Society (ANZICS) Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 356 (2000) 2139-2143
50. Van den Berghe G., and de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24 (1996) 1580-1590
51. Oberbeck R., Schmitz D., Wilsenack K., et al. Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Med 32 (2006) 731-739
52. Sakr Y., Reinhart K., Vincent J.L., et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34 (2006) 589-597
53. Povoa P.R., Carneiro A.H., Ribeiro O.S., et al. Influence of vasopressor agent in septic shock mortality: results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study). Crit Care Med 37 (2009) 410-416
54. DeBacker D. Comparison of dopamine and norepinephrine as the first vasopressor agent in the management of shock. Presented, European Society of Intensive Care Medicine 2008.
55. Martin C., Perrin G., Saux P., et al. Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med 20 (1994) 444-447
56. Martin C., Saux P., Eon B., et al. Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 34 (1990) 413-417
57. Schreuder W.O., Schneider A.J., Groeneveld A.B.J., et al. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Chest 95 (1989) 1282-1288
58. Levy B., Bollaert P.E., Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23 (1997) 282-287
59. Martin C., Viviand X., Arnaud S., et al. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients. Crit Care Med 27 (1999) 1708-1713
60. Chernow B., and Roth B.L. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 18 (1986) 141-155
61. Murakawa K., and Kobayashi A. Effects of vasopressors on renal tissue gas tensions during hemorrhagic shock in dogs. Crit Care Med 16 (1988) 789-792
62. Conger J.D., Robinette J.B., and Guggenheim S.J. Effect of acetylcholine on the early phase of reversible norepinephrine-induced acute renal failure. Kidney Int 19 (1981) 399-409
63. Schaer G.L., Fink M.P., and Parrillo J.E. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 13 (1985) 492-496
64. Albanese J., Leone M., Garnier F., et al. Renal effects of norepinephrine in septic and nonseptic patients. Chest 126 (2004) 534-539
65. De Backer D., Creteur J., Silva E., et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med 31 (2003) 1659-1667
66. Martin C., Viviand X., Leone M., et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28 (2000) 2758-2765
67. Yamazaki T., Shimada Y., Taenaka N., et al. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 10 (1982) 432-435
68. Flancbaum L., Dick M., Dasta J., et al. A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 51 (1997) 461-465
69. Gregory J.S., Bonfiglio M.F., Dasta J.F., et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 19 (1991) 1395-1400
70. Morelli A., Lange M., Ertmer C., et al. Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: a crossover pilot study. Shock 29 (2008) 446-451
71. Morelli A., Ertmer C., Rehberg S., et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 12 (2008) R143
72. Wilson W., Lipman J., Scribante J., et al. Septic shock: does adrenaline have a role as a first-line inotropic agent?. Anesth Intens Care 20 (1992) 470-474
73. Moran J.L., O'Fathartaigh M.S., Peisach A.R., et al. Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 21 (1993) 70-77
74. Mackenzie S.J., Kapadia F., Nimmo G.R., et al. Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport. Intensive Care Med 17 (1991) 36-39
75. Le Tulzo Y., Seguin P., Gacouin A., et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary study. Intensive Care Med 23 (1997) 664-670
76. Day N.P., Phu N.H., Bethell D.P., et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348 (1996) 219-223
77. Meier-Hellmann A., Reinhart K., Bredle D.L., et al. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25 (1997) 399-404
78. Zhou S.X., Qiu H.B., Huang Y.Z., et al. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 23 (2002) 654-658
79. Martikainen T.J., Tenhunen J.J., Giovannini I., et al. Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO(2) content gradients and lactate-to-pyruvate ratios. Am J Physiol Gastrointest Liver Physiol 288 (2005) G586-G592
80. Seguin P., Bellissant E., Le Tulzo Y., et al. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 71 (2002) 381-388
81. Seguin P., Laviolle B., Guinet P., et al. Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]. Crit Care 10 (2006) R32
82. Myburgh J.A., Higgins A., Jovanovska A., et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34 (2008) 2226-2234
83. Annane D., Vignon P., Renault A., et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370 (2007) 676-684
84. Holmes C.L., Patel B.M., Russell J.A., et al. Physiology of vasopressin relevant to management of septic shock. Chest 120 (2001) 989-1002
85. Barrett B.J., and Parfrey P.S. Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 354 (2006) 379-386
86. Kusano E., Tian S., Umino T., et al. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells. J Hypertens 15 (1997) 627-632
87. Wakatsuki T., Nakaya Y., and Inoue I. Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol 263 (1992) H491-H496
88. Abboud F.M., Floras J.S., Aylward P.E., et al. Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 27 (1990) 106-115
89. Wang B.C., Flora-Ginter G., Leadley Jr. R.J., et al. Ventricular receptors stimulate vasopressin release during hemorrhage. Am J Physiol 254 (1988) R204-R211
90. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997) 1122-1125
91. Sharshar T., Carlier R., Blanchard A., et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 30 (2002) 497-500
92. Sharshar T., Blanchard A., Paillard M., et al. Circulating vasopressin levels in septic shock. Crit Care Med 31 (2003) 1752-1758
93. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25 (1997) 1279-1282
94. Tsuneyoshi I., Yamada H., Kakihana Y., et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29 (2001) 487-493
95. Holmes C.L., Walley K.R., Chittock D.R., et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27 (2001) 1416-1421
96. Patel B.M., Chittock D.R., Russell J.A., et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96 (2002) 576-582
97. Dunser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319
98. Albanese J., Leone M., Delmas A., et al. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33 (2005) 1897-1902
99. van Haren F.M., Rozendaal F.W., and van der Hoeven J.G. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124 (2003) 2256-2260
100. Klinzing S., Simon M., Reinhart K., et al. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31 (2003) 2646-2650
101. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358 (2008) 877-887
102. Parker M.M., Shelhamer J.H., Bacharach S.L., et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100 (1984) 483-490
103. Jardin F., Fourme T., Page B., et al. Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 116 (1999) 1354-1359
104. Vieillard-Baron A., Caille V., Charron C., et al. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 36 (2008) 1701-1706
105. Ognibene F.P., Parker M.M., Natanson C., et al. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 93 (1988) 903-910
106. Hollenberg S.M., Cunnion R.E., Lawrence M., et al. Tumor necrosis factor depresses myocardial cell function: results using an in vitro assay of myocyte performance. [abstract]. Clin Res 37 (1989) 528A
107. Kumar A., Thota V., Dee L., et al. Tumor necrosis factor-a and interleukin-1b are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996) 949-958
108. Balligand J.-L., Ungureanu-Longrois D., Simmons W.W., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 269 (1994) 27580-27588
109. Ferdinandy P., Danial H., Ambrus I., et al. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87 (2000) 241-247
110. Layland J., Cave A.C., Warren C., et al. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J 19 (2005) 1137-1139
111. Astiz M., Rackow E.C., Weil M.H., et al. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock 26 (1988) 311-320
112. Tuchschmidt J., Fried J., Astiz M., et al. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 102 (1992) 216-220
113. Gattinoni L., Brazzi L., Pelosi P., et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333 (1995) 1025-1032
114. Hayes M.A., Timmins A.C., Yau E.H.S., et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330 (1994) 1717-1722
115. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 (2008) 296-327
116. Bakker J., Coffemils M., Leon M., et al. Blood lactates are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 99 (1992) 956-962
117. Jardin F., Sportiche M., Bazin M., et al. Dobutamine: a hemodynamic evaluation in human septic shock. Crit Care Med 9 (1981) 329-332
118. Vincent J.L., Roman A., and Kahn R.J. Dobutamine administration in septic shock: addition to a standard protocol. Crit Care Med 18 (1990) 689-693
119. De Backer D., Berre J., Zhang H., et al. Relationship between oxygen uptake and oxygen delivery in septic patients: effects of prostacyclin versus dobutamine. Crit Care Med 21 (1993) 1658-1664
120. Vallet B., Chopin C., Curtis S.E., et al. Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study. Crit Care Med 21 (1993) 1868-1875
121. Gutierrez G., Clark C., Brown S.D., et al. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150 (1994) 324-329
122. Cariou A., Pinsky M.R., Monchi M., et al. Is myocardial adrenergic responsiveness depressed in human septic shock?. Intensive Care Med 34 (2008) 917-922
123. Barton P., Garcia J., Kouatli A., et al. Hemodynamic effects of I.V. milrinone lactate in pediatric patients with septic shock: a prospective, double-blinded, randomized, placebo- controlled, interventional study. Chest 109 (1996) 1302-1312
124. Pinto B.B., Rehberg S., Ertmer C., et al. Role of levosimendan in sepsis and septic shock. Curr Opin Anaesthesiol 21 (2008) 168-177
125. Morelli A., De Castro S., Teboul J.L., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31 (2005) 638-644
126. Morelli A., Teboul J.L., Maggiore S.M., et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 34 (2006) 2287-2293